Clorox (CLX) Given a $147.00 Price Target at BMO Capital Markets

BMO Capital Markets set a $147.00 price objective on Clorox (NYSE:CLX) in a research note released on Monday, Marketbeat.com reports. The brokerage currently has a buy rating on the stock.

Several other brokerages have also issued reports on CLX. Zacks Investment Research raised Clorox from a sell rating to a hold rating in a research report on Monday, November 6th. Morgan Stanley decreased their target price on Clorox from $138.00 to $128.00 and set an equal weight rating for the company in a research report on Thursday, November 2nd. Consumer Edge raised Clorox from a neutral rating to an outperform rating in a research report on Friday, November 10th. Jefferies Group reaffirmed a hold rating and set a $132.00 target price on shares of Clorox in a research report on Wednesday, November 1st. Finally, Wells Fargo & Co raised their target price on Clorox from $130.00 to $146.00 and gave the company a market perform rating in a research report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company’s stock. Clorox has a consensus rating of Hold and a consensus target price of $131.97.

Shares of Clorox (NYSE CLX) opened at $127.76 on Monday. The company has a market capitalization of $16,540.42, a price-to-earnings ratio of 23.11, a P/E/G ratio of 2.60 and a beta of 0.31. Clorox has a 12-month low of $124.09 and a 12-month high of $150.40. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86.

Clorox (NYSE:CLX) last released its quarterly earnings results on Friday, February 2nd. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. Clorox’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 EPS. equities analysts anticipate that Clorox will post 6.23 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a dividend yield of 2.63%. Clorox’s payout ratio is 55.45%.

In other news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the transaction, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.00% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of CLX. FMR LLC boosted its stake in Clorox by 0.8% in the 2nd quarter. FMR LLC now owns 106,828 shares of the company’s stock worth $14,234,000 after purchasing an additional 879 shares during the period. Dimensional Fund Advisors LP boosted its stake in Clorox by 7.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 472,584 shares of the company’s stock worth $62,967,000 after purchasing an additional 31,843 shares during the period. Balyasny Asset Management LLC boosted its stake in Clorox by 98.2% in the 2nd quarter. Balyasny Asset Management LLC now owns 33,292 shares of the company’s stock worth $4,436,000 after purchasing an additional 16,497 shares during the period. AHL Partners LLP boosted its stake in Clorox by 18.6% in the 2nd quarter. AHL Partners LLP now owns 25,699 shares of the company’s stock worth $3,424,000 after purchasing an additional 4,028 shares during the period. Finally, Gotham Asset Management LLC bought a new position in Clorox in the 2nd quarter worth about $703,000. Institutional investors and hedge funds own 73.68% of the company’s stock.

WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.com-unik.info/2018/02/09/clorox-clx-given-a-147-00-price-target-at-bmo-capital-markets.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit